Smart insulin pumps put to the test in thousands of diabetes patients
NCT ID NCT04414280
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 1,600 people with type 1 diabetes, including young children aged 2-6, who use hybrid closed-loop insulin pumps (Medtronic, Tandem, or Omnipod). These devices automatically adjust insulin based on blood sugar readings but still require users to enter meal information. The goal is to see how well these pumps improve blood sugar control and quality of life over 24 months in real-world conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hybrid closed-loop insulin pumps (Medtronic MiniMed 670G/780G, Tandem t:Slim X2 Control-IQ, Omnipod 5)
- What this could lead to
- If successful, this could show that automated insulin pumps help people with type 1 diabetes maintain better blood sugar levels with less effort, improving daily life and reducing complications.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. The devices still require user input for meals, and long-term benefits or risks are not yet fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AZ Delta
Roeselare, 8800, Belgium
-
AZ Delta - pediatrics
Roeselare, 8800, Belgium
-
AZ Groeninge - campus kennedylaan
Kortrijk, 8500, Belgium
-
AZ Oostende
Ostend, 8400, Belgium
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
AZ Sint-Jan - pediatrics
Bruges, 8000, Belgium
-
AZ Turnhout - pediatrics
Turnhout, 2300, Belgium
-
AZORG
Aalst, 9300, Belgium
-
CHR Citadelle
Liège, 4000, Belgium
-
CHR Citadelle - pediatrics
Liège, 4030, Belgium
-
CHU Helora
Mons, 7000, Belgium
-
CHU UCL Namur - pediatrics
Yvoir, 5530, Belgium
-
CHU de Liège - site du Sart Tilman
Liège, 4000, Belgium
-
Clinique CHC Montlégia
Liège, 4000, Belgium
-
Clinique CHC Montlégia - pediatrics
Liège, 4000, Belgium
-
Cliniques Universitaires St. Luc
Brussels, 1200, Belgium
-
Cliniques Universitaires St. Luc - pediatrics
Brussels, 1200, Belgium
-
GZA Ziekenhuizen - campus Sint-Augustinus
Wilrijk, 2610, Belgium
-
GZA Ziekenhuizen - campus Sint-Vincentius
Antwerp, 2018, Belgium
-
Grand Hôpital de Charleroi - pediatrics
Charleroi, 6000, Belgium
-
Hôpital Erasme
Brussels, 1070, Belgium
-
Hôpital Universitaire des Enfants Reine Fabiola - pediatrics
Brussels, 1020, Belgium
-
Hôpital d'Arlon
Arlon, 6700, Belgium
-
Imeldaziekenhuis
Bonheiden, 2820, Belgium
-
Jessa
Hasselt, 3500, Belgium
-
Jessa - pediatrics
Hasselt, 3500, Belgium
-
UZ Antwerpen
Edegem, 2650, Belgium
-
UZ Antwerpen - pediatrics
Edegem, 2650, Belgium
-
UZ Brussel
Jette, 1090, Belgium
-
UZ Brussel - pediatrics
Jette, 1090, Belgium
-
UZ Gent
Ghent, 9000, Belgium
-
UZ Gent - pediatrics
Ghent, 9000, Belgium
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
-
VITAZ
Sint-Niklaas, 9100, Belgium
-
Vitaz - pediatrics
Sint-Niklaas, 9100, Belgium
-
ZAS - pediatrics
Antwerp, 2020, Belgium
-
ZOL Maas en Kempen - pediatrics
Maaseik, 3680, Belgium
-
ZOL Sint-Jan
Genk, 3600, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can a peptide tame type 1 diabetes?
- Can a tiny implant track glucose, ketones, and lactate in diabetes?
- Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis
- A smarter insulin that aims for the liver could curb dangerous nighttime dips
- Smart insulin pump may boost brain and body health in older adults with diabetes